These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8858386)

  • 21. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens.
    Honeyman MC; Stone NL; Falk BA; Nepom G; Harrison LC
    J Immunol; 2010 Feb; 184(4):2204-10. PubMed ID: 20083660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to human glutamic acid decarboxylase in sera from enterovirus-immunized rabbit.
    Sarmiento L; Cabrera-Rode E; Mas-Lago P; Díaz-Horta O
    Autoimmunity; 2007 Nov; 40(7):546-7. PubMed ID: 17966046
    [No Abstract]   [Full Text] [Related]  

  • 24. T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase.
    Aoki K; Taniyama M; Nagayama C; Oikawa Y; Shimada A
    Ann N Y Acad Sci; 2006 Oct; 1079():181-5. PubMed ID: 17130552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).
    Quinn A; Sercarz EE
    J Autoimmun; 1996 Jun; 9(3):365-70. PubMed ID: 8816972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Can a vaccine soon prevent type I diabetes mellitus ?].
    Kelm-Kahl I
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1816. PubMed ID: 14518433
    [No Abstract]   [Full Text] [Related]  

  • 27. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
    Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
    Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
    Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
    Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitopes of GAD 65 in insulin-dependent diabetes mellitus.
    Armstrong NW; Jones DB
    Lancet; 1994 Aug; 344(8919):406-7. PubMed ID: 7519712
    [No Abstract]   [Full Text] [Related]  

  • 30. Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes.
    Cainelli F; Manzaroli D; Renzini C; Casali F; Concia E; Vento S
    Diabetes Care; 2000 Jul; 23(7):1021-2. PubMed ID: 10895859
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular mimicry and the T-cell repertoire.
    Baum H; Peakman M; Norazmi MN; Vergani D
    Diabetologia; 1996 Feb; 39(2):246-7. PubMed ID: 8635680
    [No Abstract]   [Full Text] [Related]  

  • 32. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.
    Atkinson M; Leslie DR
    J Endocrinol Invest; 1994; 17(7):581-4. PubMed ID: 7829833
    [No Abstract]   [Full Text] [Related]  

  • 33. Two cases of "fulminant" type 1 diabetes suggesting involvement of autoimmunity.
    Nakagawa Y; Shimada A; Oikawa Y; Irie J; Shigihara T; Tsumura K; Narumi S; Saruta T
    Ann N Y Acad Sci; 2003 Nov; 1005():359-61. PubMed ID: 14679092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical significance of an autoimmune response against glutamic acid decarboxylase.
    Ellis TM; Atkinson MA
    Nat Med; 1996 Feb; 2(2):148-53. PubMed ID: 8574952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular and humoral immunity in patients with insulin-dependent diabetes.
    Hawke S; Harcourt G; Pantic N; Beeson D; Willcox N; Newson-Davis J
    Lancet; 1993 Jul; 342(8865):246. PubMed ID: 8100970
    [No Abstract]   [Full Text] [Related]  

  • 36. Autoimmunity and insulin-dependent diabetes.
    Lowdell M; Bottazzo GF
    Lancet; 1993 May; 341(8857):1378-9. PubMed ID: 8098796
    [No Abstract]   [Full Text] [Related]  

  • 37. Are T-cell responses to GAD65 influential in type 1 diabetes?
    Quinn A
    Diabetes; 2009 Dec; 58(12):2729-30. PubMed ID: 19940237
    [No Abstract]   [Full Text] [Related]  

  • 38. Autoimmune (type 1) diabetes in young adults in Sweden.
    Ostman J; Lernmark A; Landin-Olsson M; Sundkvist G; Palmer J; Arnqvist H; Blohmé G; Lithner F; Littorin B; Nyström L; Scherstén B; Wibell L
    Horm Metab Res; 1996 Jul; 28(7):348-50. PubMed ID: 8858383
    [No Abstract]   [Full Text] [Related]  

  • 39. Glutamic Acid decarboxylase therapy for recent-onset type 1 diabetes: are we at the end or the beginning of finding a cure?
    Fleming GA; Klonoff DC
    J Diabetes Sci Technol; 2009 Mar; 3(2):215-8. PubMed ID: 20144352
    [No Abstract]   [Full Text] [Related]  

  • 40. Prediction of diabetes and response to therapy in individual animals: are there lessons for man? Report on the JDF/Snow Mountain Meeting, 5-7 October 2000, Winter Park, CO, USA.
    Haskins K; Atkinson M
    J Autoimmun; 2001 Feb; 16(1):15-9. PubMed ID: 11221992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.